Veterinary/Animal Vaccines Market Product (Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture), Diseases (Rabies, FMD, Swine Influenza, Strangles, Furunculous), Technology (DNA, Recombinant, Inactivated, Conjugate) - Forecast to 2021
“Veterinary/Animal Vaccines Market, Product [Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture], Diseases [Rabies, FMD, Swine Influenza, Strangles, Furunculosis], Technology [DNA, Recombinant, Inactivated, Conjugate] - Forecast to 2021”
Increase In Livestock Population And Repeated Breakouts Of Livestock Diseases, Increasing Incidence Of Zoonotic Diseases, Initiatives By Various Government Agencies, Animal Associations, And Leading Players, And The Introduction Of New Vaccine Types To Drive the Growth of Veterinary Vaccine Market
In this market, primary investment opportunities are in emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India; these are lucrative markets for veterinary vaccines, owing to favorable government initiatives.
The global veterinary vaccines market is poised to reach USD 7.68 billion by 2021 from USD 5.81 billion in 2016, at a CAGR of 5.8% from 2016 to 2021.
The report segments the veterinary vaccines market on the basis of products, diseases, technologies, and region. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. In this market, companion animal vaccines form the fastest-growing product segment, due to the increasing number of zoonotic diseases in the human population and the growing number of pet owners worldwide.
The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to account for the highest growth of the veterinary vaccines market in 2016, due to innovations in technology and increased public awareness about animal vaccination.
New and innovative product launches and collaboration were the dominant strategies adopted by companies in this market.
This research report focuses on qualitative data, market size, and the growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and government initiatives. The competitive landscape covers growth strategies adopted by industry players in the last three years. Company profiles comprise basic views on key players in the veterinary vaccines market and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the veterinary vaccines market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
Increase In Livestock Population And Repeated Breakouts Of Livestock Diseases, Increasing Incidence Of Zoonotic Diseases, Initiatives By Various Government Agencies, Animal Associations, And Leading Players, And The Introduction Of New Vaccine Types To Drive the Growth of Veterinary Vaccine Market
In this market, primary investment opportunities are in emerging and immature markets such as the Middle East, Brazil, Argentina, Mexico, Turkey, China, and India; these are lucrative markets for veterinary vaccines, owing to favorable government initiatives.
The global veterinary vaccines market is poised to reach USD 7.68 billion by 2021 from USD 5.81 billion in 2016, at a CAGR of 5.8% from 2016 to 2021.
The report segments the veterinary vaccines market on the basis of products, diseases, technologies, and region. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines. In this market, companion animal vaccines form the fastest-growing product segment, due to the increasing number of zoonotic diseases in the human population and the growing number of pet owners worldwide.
The major animal vaccine production technologies include live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. The DNA vaccines segment is expected to account for the highest growth of the veterinary vaccines market in 2016, due to innovations in technology and increased public awareness about animal vaccination.
New and innovative product launches and collaboration were the dominant strategies adopted by companies in this market.
This research report focuses on qualitative data, market size, and the growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats). The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and government initiatives. The competitive landscape covers growth strategies adopted by industry players in the last three years. Company profiles comprise basic views on key players in the veterinary vaccines market and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss basic views on the competitive landscape; emerging and high-growth segments of the veterinary vaccines market; high-growth regions; and market drivers, restraints, and opportunities.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on products offered by top players in the veterinary vaccines market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the veterinary vaccines market
- Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for veterinary vaccines across various regions
- Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the veterinary vaccines market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and the manufacturing capabilities of leading players in the veterinary vaccines market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.2.1 Key industry insights
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 VETERINARY VACCINES MARKET (2016-2021) TO GROW AT A STEADY RATE
4.2 VETERINARY VACCINES MARKET, BY PRODUCT
4.3 VETERINARY VACCINES MARKET, BY REGION
4.4 LIFECYCLE ANALYSIS, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increase in livestock population and repeated breakouts of livestock diseases
5.2.1.2 Rise in incidences of zoonotic diseases
5.2.1.3 Initiatives by various government agencies, animal associations, and leading players
5.2.1.4 Introduction of new types of vaccines
5.2.2 RESTRAINTS
5.2.2.1 Rising costs for the storage of vaccines
5.2.2.2 Increasing prices of meat promoting the adoption of vegetarian diets
5.2.3 OPPORTUNITIES
5.2.3.1 Technological innovation
5.2.3.2 Growing awareness of animal health in emerging economies
5.2.4 CHALLENGE
5.2.4.1 Inadequate surveillance and reporting systems
6 VETERINARY VACCINES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.1.1 PORCINE VACCINES
6.1.2 POULTRY VACCINES
6.1.3 LIVESTOCK VACCINES
6.1.4 COMPANION ANIMAL VACCINES
6.1.5 EQUINE VACCINES
6.1.6 AQUACULTURE VACCINES
6.1.7 OTHER ANIMAL VACCINES
7 VETERINARY VACCINES MARKET, BY DISEASE
7.1 INTRODUCTION
7.2 PORCINE VACCINES
7.3 POULTRY VACCINES
7.4 LIVESTOCK VACCINES
7.4.1 BOVINE VACCINES
7.4.2 SMALL RUMINANT VACCINES
7.5 COMPANION ANIMAL VACCINES
7.5.1 CANINE VACCINES
7.5.2 FELINE VACCINES
7.6 EQUINE VACCINES
7.7 AQUACULTURE VACCINES
8 VETERINARY VACCINES MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 LIVE ATTENUATED VACCINES
8.3 INACTIVATED VACCINES
8.4 TOXOID VACCINES
8.5 RECOMBINANT VACCINES
8.6 CONJUGATE VACCINES
8.7 SUBUNIT VACCINES
8.8 DNA VACCINES
9 VETERINARY VACCINES MARKET, BY REGION
9.1 INTRODUCTION
9.2 EUROPE
9.3 NORTH AMERICA
9.4 ASIA
9.4.1 CHINA
9.4.2 THAILAND
9.4.2.1 Regulatory landscape for veterinary vaccines in Thailand
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.4.1 Regulatory scenario
9.4.4.1.1 Regulatory authorities: veterinary health and safety
9.4.4.2 Related regulations
9.4.4.3 Regulatory requirements
9.4.4.4 Quality and safety control system
9.5 REST OF THE WORLD (ROW)
9.5.1 BRAZIL
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIC ANALYSIS
10.3 MARKET SHARE ANALYSIS
10.4 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS, BY PRODUCT (2013–2015)
10.4.1 RECENT NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS BY MARKET PLAYER (2013–2016)
10.4.1.1 Zoetis (PFIZER)
10.4.1.2 Merck animal health
10.4.1.3 Boehringer Ingelheim Inc.
10.4.1.4 Ceva animal health
10.5 COMPETITIVE SITUATION AND TRENDS
10.5.1 NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS
10.5.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.5.3 ACQUISITIONS
10.5.4 EXPANSIONS
10.5.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 INTRODUCTION
(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*
11.2 ZOETIS
1.3 MERCK ANIMAL HEALTH
11.4 MERIAL INC. (SANOFI)
11.5 BOEHRINGER INGELHEIM
11.6 ELANCO ANIMAL HEALTH (ELI LILLY)
11.7 BAYER HEALTHCARE
11.8 CEVA ANIMAL HEALTH
11.9 HESKA CORPORATION
11.10 VETOQUINOL
11.11 VIRBAC LTD.
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 OTHER COMPANY DEVELOPMENTS (2013–2016)
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.6 AVAILABLE CUSTOMIZATIONS
12.7 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.2.1 Key industry insights
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 INTRODUCTION
3.2 CURRENT SCENARIO
3.3 FUTURE OUTLOOK
3.4 CONCLUSION
4 PREMIUM INSIGHTS
4.1 VETERINARY VACCINES MARKET (2016-2021) TO GROW AT A STEADY RATE
4.2 VETERINARY VACCINES MARKET, BY PRODUCT
4.3 VETERINARY VACCINES MARKET, BY REGION
4.4 LIFECYCLE ANALYSIS, BY REGION
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increase in livestock population and repeated breakouts of livestock diseases
5.2.1.2 Rise in incidences of zoonotic diseases
5.2.1.3 Initiatives by various government agencies, animal associations, and leading players
5.2.1.4 Introduction of new types of vaccines
5.2.2 RESTRAINTS
5.2.2.1 Rising costs for the storage of vaccines
5.2.2.2 Increasing prices of meat promoting the adoption of vegetarian diets
5.2.3 OPPORTUNITIES
5.2.3.1 Technological innovation
5.2.3.2 Growing awareness of animal health in emerging economies
5.2.4 CHALLENGE
5.2.4.1 Inadequate surveillance and reporting systems
6 VETERINARY VACCINES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.1.1 PORCINE VACCINES
6.1.2 POULTRY VACCINES
6.1.3 LIVESTOCK VACCINES
6.1.4 COMPANION ANIMAL VACCINES
6.1.5 EQUINE VACCINES
6.1.6 AQUACULTURE VACCINES
6.1.7 OTHER ANIMAL VACCINES
7 VETERINARY VACCINES MARKET, BY DISEASE
7.1 INTRODUCTION
7.2 PORCINE VACCINES
7.3 POULTRY VACCINES
7.4 LIVESTOCK VACCINES
7.4.1 BOVINE VACCINES
7.4.2 SMALL RUMINANT VACCINES
7.5 COMPANION ANIMAL VACCINES
7.5.1 CANINE VACCINES
7.5.2 FELINE VACCINES
7.6 EQUINE VACCINES
7.7 AQUACULTURE VACCINES
8 VETERINARY VACCINES MARKET, BY TECHNOLOGY
8.1 INTRODUCTION
8.2 LIVE ATTENUATED VACCINES
8.3 INACTIVATED VACCINES
8.4 TOXOID VACCINES
8.5 RECOMBINANT VACCINES
8.6 CONJUGATE VACCINES
8.7 SUBUNIT VACCINES
8.8 DNA VACCINES
9 VETERINARY VACCINES MARKET, BY REGION
9.1 INTRODUCTION
9.2 EUROPE
9.3 NORTH AMERICA
9.4 ASIA
9.4.1 CHINA
9.4.2 THAILAND
9.4.2.1 Regulatory landscape for veterinary vaccines in Thailand
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.4.1 Regulatory scenario
9.4.4.1.1 Regulatory authorities: veterinary health and safety
9.4.4.2 Related regulations
9.4.4.3 Regulatory requirements
9.4.4.4 Quality and safety control system
9.5 REST OF THE WORLD (ROW)
9.5.1 BRAZIL
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIC ANALYSIS
10.3 MARKET SHARE ANALYSIS
10.4 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS, BY PRODUCT (2013–2015)
10.4.1 RECENT NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS BY MARKET PLAYER (2013–2016)
10.4.1.1 Zoetis (PFIZER)
10.4.1.2 Merck animal health
10.4.1.3 Boehringer Ingelheim Inc.
10.4.1.4 Ceva animal health
10.5 COMPETITIVE SITUATION AND TRENDS
10.5.1 NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS
10.5.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.5.3 ACQUISITIONS
10.5.4 EXPANSIONS
10.5.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 INTRODUCTION
(Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, Ratio Analysis, MnM View)*
11.2 ZOETIS
1.3 MERCK ANIMAL HEALTH
11.4 MERIAL INC. (SANOFI)
11.5 BOEHRINGER INGELHEIM
11.6 ELANCO ANIMAL HEALTH (ELI LILLY)
11.7 BAYER HEALTHCARE
11.8 CEVA ANIMAL HEALTH
11.9 HESKA CORPORATION
11.10 VETOQUINOL
11.11 VIRBAC LTD.
*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS OF INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 OTHER COMPANY DEVELOPMENTS (2013–2016)
12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.6 AVAILABLE CUSTOMIZATIONS
12.7 RELATED REPORTS
LIST OF TABLES
Table 1 REPORTED ZOONOSES (2012-1016)
Table 2 GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE THE VETERINARY VACCINES MARKET
Table 3 HIGH STORAGE COST OF VACCINES TO RESTRAIN MARKET GROWTH
Table 4 TECHNOLOGICAL ADVANCEMENTS, A KEY AREA OF OPPORTUNITY IN THE MARKET
Table 5 INADEQUATE SURVEILLANCE AND REPORTING SYSTEMS IS A MAJOR CHALLENGE IN THE MARKET
Table 6 VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 7 PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 8 POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 9 LIVESTOCK VACCINES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 10 BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 11 SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 12 COMPANION ANIMAL VACCINES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 13 CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 14 FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 15 EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 16 AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 17 VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 18 LIVE ATTENUATED VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 19 INACTIVATED VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 20 TOXOID VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 21 RECOMBINANT VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 22 CONJUGATE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 23 SUBUNIT VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 24 DNA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 25 VETERINARY VACCINES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 26 EUROPE: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 27 EUROPE: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 28 EUROPE: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 29 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 30 EUROPE: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 31 EUROPE: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 32 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 33 EUROPE: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 34 EUROPE: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 35 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 36 EUROPE: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 37 EUROPE: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 38 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 39 EUROPE: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 40 EUROPE: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 41 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 42 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 43 NORTH AMERICA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 44 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 45 NORTH AMERICA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 46 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 47 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 48 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 49 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 50 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 51 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 52 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 53 NORTH AMERICA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 54 NORTH AMERICA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 55 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 56 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 57 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 58 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 59 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 60 CHINA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 61 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 62 CHINA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 63 CHINA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 64 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 65 CHINA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 66 CHINA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 67 CHINA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 68 CHINA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 69 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 70 CHINA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 71 CHINA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 72 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 73 CHINA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 74 CHINA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 75 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 76 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 77 THAILAND: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 78 THAILAND: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 79 THAILAND: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 80 THAILAND: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 81 THAILAND: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 82 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 83 THAILAND: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 84 THAILAND: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 85 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 86 THAILAND: LIVESTOCK ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 87 THAILAND: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 88 THAILAND: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 89 THAILAND: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 90 INDIA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 91 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 92 INDIA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 93 INDIA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 94 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 95 INDIA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 96 INDIA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 97 INDIA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 98 INDIA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 99 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 100 INDIA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 101 INDIA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 102 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 103 INDIA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 104 INDIA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 105 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 106 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 107 SOUTH KOREA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 108 SOUTH KOREA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 109 SOUTH KOREA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 110 SOUTH KOREA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 111 SOUTH KOREA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 112 SOUTH KOREA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 113 SOUTH KOREA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 114 SOUTH KOREA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 115 SOUTH KOREA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 116 SOUTH KOREA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 117 SOUTH KOREA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 118 SOUTH KOREA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 119 SOUTH KOREA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 120 SOUTH KOREA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 121 SOUTH KOREA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 122 BRAZIL: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 123 BRAZIL: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 124 BRAZIL: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 125 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 126 BRAZIL: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 127 BRAZIL: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 128 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 129 BRAZIL: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 130 BRAZIL: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 131 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 132 BRAZIL: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 133 BRAZIL: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 134 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 135 BRAZIL: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 136 BRAZIL: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 137 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 138 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 139 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013–2016)
Table 140 NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS, 2013–2016
Table 141 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016
Table 142 ACQUISITIONS, 2013–2016
Table 143 EXPANSIONS, 2013–2016
Table 144 OTHER DEVELOPMENTS, 2013–2016
Table 1 REPORTED ZOONOSES (2012-1016)
Table 2 GROWING INCIDENCE OF ZOONOTIC DISEASES TO DRIVE THE VETERINARY VACCINES MARKET
Table 3 HIGH STORAGE COST OF VACCINES TO RESTRAIN MARKET GROWTH
Table 4 TECHNOLOGICAL ADVANCEMENTS, A KEY AREA OF OPPORTUNITY IN THE MARKET
Table 5 INADEQUATE SURVEILLANCE AND REPORTING SYSTEMS IS A MAJOR CHALLENGE IN THE MARKET
Table 6 VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 7 PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 8 POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 9 LIVESTOCK VACCINES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 10 BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 11 SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 12 COMPANION ANIMAL VACCINES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
Table 13 CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 14 FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 15 EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 16 AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 17 VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 18 LIVE ATTENUATED VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 19 INACTIVATED VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 20 TOXOID VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 21 RECOMBINANT VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 22 CONJUGATE VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 23 SUBUNIT VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 24 DNA VACCINES MARKET SIZE, BY ANIMAL TYPE, 2014–2021 (USD MILLION)
Table 25 VETERINARY VACCINES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
Table 26 EUROPE: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 27 EUROPE: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 28 EUROPE: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 29 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 30 EUROPE: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 31 EUROPE: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 32 EUROPE: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 33 EUROPE: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 34 EUROPE: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 35 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 36 EUROPE: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 37 EUROPE: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 38 EUROPE: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 39 EUROPE: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 40 EUROPE: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 41 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 42 EUROPE: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 43 NORTH AMERICA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 44 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 45 NORTH AMERICA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 46 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 47 NORTH AMERICA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 48 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 49 NORTH AMERICA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 50 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 51 NORTH AMERICA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 52 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 53 NORTH AMERICA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 54 NORTH AMERICA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 55 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 56 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 57 NORTH AMERICA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 58 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 59 NORTH AMERICA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 60 CHINA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 61 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 62 CHINA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 63 CHINA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 64 CHINA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 65 CHINA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 66 CHINA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 67 CHINA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 68 CHINA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 69 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 70 CHINA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 71 CHINA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 72 CHINA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 73 CHINA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 74 CHINA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 75 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 76 CHINA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 77 THAILAND: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 78 THAILAND: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 79 THAILAND: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 80 THAILAND: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 81 THAILAND: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 82 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 83 THAILAND: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 84 THAILAND: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 85 THAILAND: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 86 THAILAND: LIVESTOCK ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 87 THAILAND: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 88 THAILAND: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 89 THAILAND: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 90 INDIA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 91 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 92 INDIA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 93 INDIA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 94 INDIA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 95 INDIA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 96 INDIA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 97 INDIA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 98 INDIA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 99 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 100 INDIA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 101 INDIA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 102 INDIA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 103 INDIA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 104 INDIA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 105 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 106 INDIA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 107 SOUTH KOREA: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 108 SOUTH KOREA: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 109 SOUTH KOREA: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 110 SOUTH KOREA: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 111 SOUTH KOREA: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 112 SOUTH KOREA: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 113 SOUTH KOREA: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 114 SOUTH KOREA: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 115 SOUTH KOREA: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 116 SOUTH KOREA: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 117 SOUTH KOREA: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 118 SOUTH KOREA: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 119 SOUTH KOREA: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 120 SOUTH KOREA: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 121 SOUTH KOREA: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 122 BRAZIL: VETERINARY VACCINES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION)
Table 123 BRAZIL: POULTRY VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 124 BRAZIL: POULTRY VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 125 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 126 BRAZIL: BOVINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 127 BRAZIL: SMALL RUMINANT VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 128 BRAZIL: LIVESTOCK VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 129 BRAZIL: PORCINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 130 BRAZIL: PORCINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 131 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY CATEGORY, 2014–2021 (USD MILLION)
Table 132 BRAZIL: CANINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 133 BRAZIL: FELINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 134 BRAZIL: COMPANION ANIMAL VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 135 BRAZIL: EQUINE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 136 BRAZIL: EQUINE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 137 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION)
Table 138 BRAZIL: AQUACULTURE VACCINES MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD MILLION)
Table 139 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013–2016)
Table 140 NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS, 2013–2016
Table 141 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016
Table 142 ACQUISITIONS, 2013–2016
Table 143 EXPANSIONS, 2013–2016
Table 144 OTHER DEVELOPMENTS, 2013–2016
LIST OF FIGURES
Figure 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET
Figure 2 MARKET SIZE ESTIMATION APPROACH
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 DATA TRIANGULATION METHODOLOGY
Figure 5 VETERINARY VACCINES MARKET, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
Figure 6 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
Figure 7 PORCINE VACCINES MARKET, BY DISEASE, 2016 VS. 2021 (USD MILLION)
Figure 8 CANINE VACCINES MARKET, BY DISEASE, 2016 VS. 2021 (USD MILLION)
Figure 9 VETERINARY VACCINES MARKET, BY REGION, 2016 (USD MILLION)
Figure 10 ATTRACTIVE MARKET OPPORTUNITIES
Figure 11 PORCINE VACCINES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2016
Figure 12 ASIA EXPECTED TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD
Figure 13 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
Figure 14 INCREASE IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES TO BOOST MARKET GROWTH
Figure 15 PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VETERINARY VACCINES MARKET IN 2016
Figure 16 PORCINE CIRCOVIRUS SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN PORCINE VACCINES MARKET, BY 2021
Figure 17 INFECTIOUS BRONCHITIS SEGMENT TO DOMINATE THE POULTRY VACCINES MARKET IN 2016
Figure 18 BVD SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE BOVINE VACCINES MARKET BY 2021
Figure 19 CLOSTRIDIAL DISEASES SEGMENT TO DOMINATE THE SMALL RUMINANT VACCINES MARKET IN 2016
Figure 20 CANINE DISTEMPER SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE CANINE VACCINES MARKET BY 2021
Figure 21 FELINE RABIES SEGMENT IS EXPECTED TO DOMINATE THE FELINE VACCINES MARKET IN 2016
Figure 22 EQUINE RHINOPNEUMONITIS SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE EQUINE VACCINES MARKET
Figure 23 VIBRIOSIS TO DOMINATE THE AQUACULTURE VACCINES MARKET, BY DISEASE, IN 2016
Figure 24 LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2016
Figure 25 POULTRY VACCINES SEGMENT IS EXPECTED TO DOMINATE THE LIVE ATTENUATED VACCINES MARKET IN 2016
Figure 26 COMPANION ANIMAL VACCINES SEGMENT TO REGISTER HIGHEST GROWTH RATE IN THE INACTIVATED VACCINES MARKET
Figure 27 LIVESTOCK VACCINES TO DOMINATE THE TOXOID VACCINES MARKET IN 2016
Figure 28 POULTRY VACCINES SEGMENT TO GROW AT THE HIGHEST RATE IN THE RECOMBINANT VACCINES MARKET
Figure 29 PORCINE VACCINES TO DOMINATE THE CONJUGATE VACCINES MARKET IN 2016
Figure 30 LIVESTOCK VACCINES TO GROW AT THE HIGHEST RATE IN THE SUBUNIT VACCINES MARKET FROM 2016 TO 2021
Figure 31 PORCINE VACCINES SEGMENT IS EXPECTED TO DOMINATE THE DNA VACCINES MARKET
Figure 32 GEOGRAPHIC SNAPSHOT: ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 33 ASIA, AN ATTRACTIVE REGION FOR ALL PRODUCT CATEGORIES
Figure 34 EUROPE WILL CONTINUE TO LEAD THE GLOBAL VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
Figure 35 THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY THE GROWING PRODUCTION OF PIG MEAT IN THE FORECAST PERIOD
Figure 36 THE PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN VETERINARY VACCINES MARKET IN 2016
Figure 37 RECOMBINANT VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN THE EUROPEAN VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD
Figure 38 THE INACTIVATED VACCINES TECHNOLOGY SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN COMPANION ANIMAL VACCINES MARKET
Figure 39 COMPANION ANIMAL VACCINES WILL BE THE FASTEST-GROWING SEGMENT FOR NORTH AMERICAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
Figure 40 THE LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN LIVESTOCK VACCINES MARKET
Figure 41 ASIA MARKET SNAPSHOT: THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY INCREASING INCIDENCES OF ZOONOTIC DISEASES
Figure 42 THE LIVESTOCK VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN CHINA
Figure 43 CONJUGATE VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN THE ASIAN VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD
Figure 44 STEPS INVOLVED IN THE MARKETING AUTHORIZATION APPROVAL OF VETERINARY VACCINES IN THAILAND
Figure 45 REGISTRATION PROCESS
Figure 46 THE PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE THAILAND VETERINARY VACCINES MARKET IN 2016
Figure 47 RECOMBINANT VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE VETERINARY VACCINES MARKET IN THAILAND DURING THE FORECAST PERIOD
Figure 48 LIVESTOCK VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN INDIA
Figure 49 CONJUGATE VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE INDIAN LIVESTOCK VACCINES MARKET
Figure 50 SOUTH KOREAN VETERINARY VACCINES MARKET: REGULATORY AUTHORITIES AND THEIR RESPECTIVE ROLES
Figure 51 PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN SOUTH KOREA
Figure 52 INACTIVATED VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE SOUTH KOREAN POULTRY VACCINES MARKET
Figure 53 POULTRY VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN BRAZIL
Figure 54 INACTIVATED VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE POULTRY VACCINES MARKET IN BRAZIL
Figure 55 KEY DEVELOPMENTS IN THE VETERINARY VACCINES MARKET, 2013-2016
Figure 56 GLOBAL VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2015
Figure 57 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013–2016)
Figure 58 ZOETIS (PFIZER) FOCUSED ON PORCINE AND POULTRY SEGMENT IN THE LAST FEW YEARS (2013-2016)
Figure 59 MERCK CONCENTRATED ON THE AQUACULTURE SEGMENT (2013-2016)
Figure 60 BOEHRINGER INGELHEIM MAINLY CONCENTRATED ON EQUINE AND PORCINE SEGMENT (2013-2016)
Figure 61 CEVA RELEASED NEW PRODUCTS FOR THE POULTRY SEGMENT (2013–2016)
Figure 62 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS—THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2013 & 2016
Figure 63 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
Figure 64 ZOETIS: COMPANY SNAPSHOT
Figure 65 MERCK ANIMAL HEALTH: COMPANY SNAPSHOT
Figure 66 MERIAL INC. (SANOFI): COMPANY SNAPSHOT
Figure 67 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
Figure 68 ELI LILLY: COMPANY SNAPSHOT
Figure 69 BAYER HEALTHCARE: COMPANY SNAPSHOT
Figure 70 CEVA ANIMAL HEALTH: COMPANY SNAPSHOT
Figure 71 HESKA CORPORATION: COMPANY SNAPSHOT
Figure 72 VETOQUINOL: COMPANY SNAPSHOT
Figure 73 VIRBAC LTD.: COMPANY SNAPSHOT
Figure 1 RESEARCH DESIGN: VETERINARY VACCINES MARKET
Figure 2 MARKET SIZE ESTIMATION APPROACH
Figure 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 4 DATA TRIANGULATION METHODOLOGY
Figure 5 VETERINARY VACCINES MARKET, BY PRODUCT, 2016 VS. 2021 (USD MILLION)
Figure 6 VETERINARY VACCINES MARKET, BY TECHNOLOGY, 2016 VS. 2021 (USD MILLION)
Figure 7 PORCINE VACCINES MARKET, BY DISEASE, 2016 VS. 2021 (USD MILLION)
Figure 8 CANINE VACCINES MARKET, BY DISEASE, 2016 VS. 2021 (USD MILLION)
Figure 9 VETERINARY VACCINES MARKET, BY REGION, 2016 (USD MILLION)
Figure 10 ATTRACTIVE MARKET OPPORTUNITIES
Figure 11 PORCINE VACCINES SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET IN 2016
Figure 12 ASIA EXPECTED TO BE THE FASTEST-GROWING REGION DURING THE FORECAST PERIOD
Figure 13 ASIAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD
Figure 14 INCREASE IN LIVESTOCK POPULATION AND REPEATED BREAKOUTS OF LIVESTOCK DISEASES TO BOOST MARKET GROWTH
Figure 15 PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL VETERINARY VACCINES MARKET IN 2016
Figure 16 PORCINE CIRCOVIRUS SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN PORCINE VACCINES MARKET, BY 2021
Figure 17 INFECTIOUS BRONCHITIS SEGMENT TO DOMINATE THE POULTRY VACCINES MARKET IN 2016
Figure 18 BVD SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE BOVINE VACCINES MARKET BY 2021
Figure 19 CLOSTRIDIAL DISEASES SEGMENT TO DOMINATE THE SMALL RUMINANT VACCINES MARKET IN 2016
Figure 20 CANINE DISTEMPER SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE CANINE VACCINES MARKET BY 2021
Figure 21 FELINE RABIES SEGMENT IS EXPECTED TO DOMINATE THE FELINE VACCINES MARKET IN 2016
Figure 22 EQUINE RHINOPNEUMONITIS SEGMENT PROJECTED TO GROW AT THE HIGHEST RATE IN THE EQUINE VACCINES MARKET
Figure 23 VIBRIOSIS TO DOMINATE THE AQUACULTURE VACCINES MARKET, BY DISEASE, IN 2016
Figure 24 LIVE ATTENUATED VACCINES SEGMENT TO DOMINATE THE VETERINARY VACCINES MARKET IN 2016
Figure 25 POULTRY VACCINES SEGMENT IS EXPECTED TO DOMINATE THE LIVE ATTENUATED VACCINES MARKET IN 2016
Figure 26 COMPANION ANIMAL VACCINES SEGMENT TO REGISTER HIGHEST GROWTH RATE IN THE INACTIVATED VACCINES MARKET
Figure 27 LIVESTOCK VACCINES TO DOMINATE THE TOXOID VACCINES MARKET IN 2016
Figure 28 POULTRY VACCINES SEGMENT TO GROW AT THE HIGHEST RATE IN THE RECOMBINANT VACCINES MARKET
Figure 29 PORCINE VACCINES TO DOMINATE THE CONJUGATE VACCINES MARKET IN 2016
Figure 30 LIVESTOCK VACCINES TO GROW AT THE HIGHEST RATE IN THE SUBUNIT VACCINES MARKET FROM 2016 TO 2021
Figure 31 PORCINE VACCINES SEGMENT IS EXPECTED TO DOMINATE THE DNA VACCINES MARKET
Figure 32 GEOGRAPHIC SNAPSHOT: ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
Figure 33 ASIA, AN ATTRACTIVE REGION FOR ALL PRODUCT CATEGORIES
Figure 34 EUROPE WILL CONTINUE TO LEAD THE GLOBAL VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
Figure 35 THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY THE GROWING PRODUCTION OF PIG MEAT IN THE FORECAST PERIOD
Figure 36 THE PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN VETERINARY VACCINES MARKET IN 2016
Figure 37 RECOMBINANT VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN THE EUROPEAN VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD
Figure 38 THE INACTIVATED VACCINES TECHNOLOGY SEGMENT EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPEAN COMPANION ANIMAL VACCINES MARKET
Figure 39 COMPANION ANIMAL VACCINES WILL BE THE FASTEST-GROWING SEGMENT FOR NORTH AMERICAN VETERINARY VACCINES MARKET IN THE FORECAST PERIOD
Figure 40 THE LIVE ATTENUATED VACCINES TECHNOLOGY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN LIVESTOCK VACCINES MARKET
Figure 41 ASIA MARKET SNAPSHOT: THE DEMAND FOR VETERINARY VACCINES WILL BE DRIVEN BY INCREASING INCIDENCES OF ZOONOTIC DISEASES
Figure 42 THE LIVESTOCK VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN CHINA
Figure 43 CONJUGATE VACCINES TECHNOLOGY WILL BE THE FASTEST-GROWING SEGMENT IN THE ASIAN VETERINARY VACCINES MARKET DURING THE FORECAST PERIOD
Figure 44 STEPS INVOLVED IN THE MARKETING AUTHORIZATION APPROVAL OF VETERINARY VACCINES IN THAILAND
Figure 45 REGISTRATION PROCESS
Figure 46 THE PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE THAILAND VETERINARY VACCINES MARKET IN 2016
Figure 47 RECOMBINANT VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE VETERINARY VACCINES MARKET IN THAILAND DURING THE FORECAST PERIOD
Figure 48 LIVESTOCK VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN INDIA
Figure 49 CONJUGATE VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE INDIAN LIVESTOCK VACCINES MARKET
Figure 50 SOUTH KOREAN VETERINARY VACCINES MARKET: REGULATORY AUTHORITIES AND THEIR RESPECTIVE ROLES
Figure 51 PORCINE VACCINES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN SOUTH KOREA
Figure 52 INACTIVATED VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE SOUTH KOREAN POULTRY VACCINES MARKET
Figure 53 POULTRY VACCINES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE VETERINARY VACCINES MARKET IN BRAZIL
Figure 54 INACTIVATED VACCINES TECHNOLOGY SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE POULTRY VACCINES MARKET IN BRAZIL
Figure 55 KEY DEVELOPMENTS IN THE VETERINARY VACCINES MARKET, 2013-2016
Figure 56 GLOBAL VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2015
Figure 57 VETERINARY VACCINES MARKET, MAJOR DEVELOPMENTS (2013–2016)
Figure 58 ZOETIS (PFIZER) FOCUSED ON PORCINE AND POULTRY SEGMENT IN THE LAST FEW YEARS (2013-2016)
Figure 59 MERCK CONCENTRATED ON THE AQUACULTURE SEGMENT (2013-2016)
Figure 60 BOEHRINGER INGELHEIM MAINLY CONCENTRATED ON EQUINE AND PORCINE SEGMENT (2013-2016)
Figure 61 CEVA RELEASED NEW PRODUCTS FOR THE POULTRY SEGMENT (2013–2016)
Figure 62 BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES, LICENSES, AND APPROVALS—THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS BETWEEN 2013 & 2016
Figure 63 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
Figure 64 ZOETIS: COMPANY SNAPSHOT
Figure 65 MERCK ANIMAL HEALTH: COMPANY SNAPSHOT
Figure 66 MERIAL INC. (SANOFI): COMPANY SNAPSHOT
Figure 67 BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
Figure 68 ELI LILLY: COMPANY SNAPSHOT
Figure 69 BAYER HEALTHCARE: COMPANY SNAPSHOT
Figure 70 CEVA ANIMAL HEALTH: COMPANY SNAPSHOT
Figure 71 HESKA CORPORATION: COMPANY SNAPSHOT
Figure 72 VETOQUINOL: COMPANY SNAPSHOT
Figure 73 VIRBAC LTD.: COMPANY SNAPSHOT
